ANELIXIS THERAPEUTICS
Anelixis Therapeutics is a clinical stage development company located in Cambridge, Massachusetts with a portfolio focused on immune modulatory drugs for neurodegenerative diseases with a focus on amyotrophic lateral sclerosis (ALS) and Alzheimer's Disease (AD). Anelixis Therapeutics is committed to advancing treatments that will have a meaningful impact on the lives of patients by helping them battle back their disease progression.
ANELIXIS THERAPEUTICS
Industry:
Biotechnology Clinical Trials Medical Product Research
Founded:
2012-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.anelixistherapeutics.com
Total Employee:
1+
Status:
Closed
Contact:
+1.617.599.6514
Total Funding:
6.86 M USD
Technology used in webpage:
Google Google Cloud Ninja Forms
Similar Organizations
AMES Technology
AMES Technology primarily develops subacute clinical trials.
BIOSA Technologies
BIOSA Technologies is an enzymatic biotechnology company headquartered in Toronto, Canada.
ExpressCells
ExpressCells creates custom cell lines for biological research and drug discovery.
Impact Proteomics
Impact Proteomics makes all inclusive kits for protein, peptide, and proteome sample preparation and clean up.
ITeos Therapeutics
ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.
LyGenesis
LyGenesis is an organ regeneration company that facilitates organ regeneration and transplant.
STC Biologics
STC Biologics is a biotechnology company that offers biologics drug research and development services.
Venquis Therapeutics
Venquis Therapeutics is a biotechnology company that focuses on chemically targeted protein degradation.
Current Employees Featured
Founder
Official Site Inspections
http://www.anelixistherapeutics.com
- Host name: 143.185.239.35.bc.googleusercontent.com
- IP address: 35.239.185.143
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Anelixis Therapeutics"
Anelixis Therapeutics - Crunchbase Company Profile
Anelixis Therapeutics is a clinical stage development company located in …See details»
Anelixis Therapeutics 2025 Company Profile: Valuation, Investors ...
Anelixis Therapeutics was acquired on 14-Sep-2020. Who acquired Anelixis Therapeutics? Anelixis Therapeutics was acquired by Eledon Pharmaceuticals. Data Transparency. Meet our …See details»
Home - Anelixis Pharmaceuticals
About us. “…at Anelixis, we are passionate about patients and their health, and we never give up in the face of any challenge, which we prefer to explore andSee details»
Anelixis Therapeutics, LLC Company Profile | Cambridge, MA ...
Find company research, competitor information, contact details & financial data for Anelixis Therapeutics, LLC of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Anelixis Therapeutics - Products, Competitors, Financials, …
Anelixis Therapeutics is a clinical stage development company with a portfolio of antibodies blocking CD40L activity. Anelixis is developing its lead compound, AT-1501, in Amyotrophic …See details»
Anelixis Therapeutics - Craft
Anelixis Therapeutics is a biotechnology company developing therapies for patients with neurodegenerative and autoimmune diseases. It is engaged in the development of antibodies …See details»
Anelixis Therapeutics - Ownership and Business Overview - Mergr
Sep 14, 2020 Anelixis Therapeutics, Inc. is a privately held clinical stage biotechnology company developing a next generation anti-CD40 Ligand (CD40L) antibody as a potential treatment for …See details»
Anelixis Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
Explore Anelixis Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 5 news, Drug:Tegoprubart.See details»
Anelixis Therapeutics to Provide Pipeline of Clinical Candidates for …
Feb 10, 2014 Anelixis Therapeutics, LLC is a mission-aligned translational medicine and drug development company created by the ALS Therapy Development Institute in 2013.It uses …See details»
ANELIXIS THERAPEUTICS INC Burlington MA, 01803 - Company …
Free Business profile for ANELIXIS THERAPEUTICS INC at 1500 District Ave, Burlington, MA, 01803-5069, US. ANELIXIS THERAPEUTICS INC specializes in: Pharmaceutical Preparations.See details»
Anelixis Therapeutics - VentureRadar
Anelixis Therapeutics VentureRadar profile. Find out more about Anelixis Therapeutics, Antibodies and Biologics.See details»
Novus Therapeutics Announces Acquisition of Anelixis Therapeutics
Sep 14, 2020 Novus Therapeutics, Inc. (“Novus”) (NASDAQ: NVUS) today announced it has completed the acquisition of Anelixis Therapeutics, Inc. (“Anelixis”), a privately held clinical …See details»
Anelixis Therapeutics - Contacts, Employees, Board Members, …
Anelixis Therapeutics is a biotechnology company that facilitates pre-clinical drug development. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. …See details»
Anelixis Therapeutics CEO and Key Executive Team | Craft.co
Anelixis Therapeutics's Founder, CEO & Director is Steven Perrin. Other executives include Pamela Gustafson, Vice President of Clinical Operations & Compliance; Michelle A. Baron, …See details»
Acquisition of Anelixis Therapeutics Fuels Hopes for ALS
Sep 14, 2020 About Anelixis Therapeutics Anelixis Therapeutics, Inc. was a clinical stage, privately held biotechnology company developing treatments for patients with …See details»
Anelixis Therapeutics, LLC. - Drug pipelines, Patents ... - Patsnap
Explore Anelixis Therapeutics, LLC. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 1 news, Drug:Tegoprubart.See details»
Novus Therapeutics Announces Acquisition of Anelixis Therapeutics
Novus Therapeutics Announces Acquisition of Anelixis Therapeutics September 14, 2020 Acquisition includes lead clinical-stage compound AT-1501, a next generation anti-CD40L …See details»
About Us - Anelixis Pharmaceuticals
We can adapt our offering to perfectly match your current or future needs and strategic direction, representing your organization in the region and successfully commercializing your strategic …See details»
Novus Announces Acquisition of Anelixis - Drug Development and …
Novus Therapeutics, Inc. recently announced it has completed the acquisition of Anelixis Therapeutics, Inc., a privately held clinical-stage biotechnology company developing a next …See details»
Portfolio / PARTNERSHIPS - Anelixis Pharmaceuticals
Anelixis is joining forces with pharma partners to bring innovative therapies to patients in need in Greece & Cyprus.See details»